In conclusion, our study reveals that CRC patients present at diagnosis with elevated levels of MVs, namely total MVs, MUC-1-positive MVs, TF-positive MVs, and EMVs, with statistical significance compared to controls, even in very early stages of the disease. The gene discussed is TF; the disease is colorectal carcinoma.